Do you suffer from Atopic Dermatitis or Eczema?

Brookline MA

Description

You may qualify for a clinical research study! The ADopt‐VA Atopic Dermatitis Study is evaluating an investigational medication for the treatment of (Atopic Dermatitis) (or) (Eczema). The goal of the study is to evaluate the immune response to common vaccinations for participants receiving the investigational medication. Participating in this study does not disqualify you from receiving the COVID‐19 vaccine, nor does it require you to receive it. The COVID‐19 vaccine is not being studied in this clinical trial. You may pre‐qualify for the ADopt‐VA Atopic Dermatitis Study if you: • Are 18 to 55 years old • Have had Atopic Dermatitis/Eczema for at least one year • Have used another Eczema treatment or cream that did not fully treat your Eczema